Orforglipron Topline Results & ADCES 2025 Part 1

from Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives · host Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, share key insights and takeaways from the Association of Diabetes Care and Education Specialists (ADCES) 2025 annual meeting.00:00:00 Introduction00:00:25 Orforglipron and the ATTAIN-1 study00:01:29 Why orforglipron is exciting00:04:21 ADCES - Incredible Incretins00:10:33 ADCES - AI in diabetes management00:12:59 New AI tools for endocrinology00:19:01 ADCES - Implicit bias00:21:30 Closing

Episode metadata supplied by the publisher feed · Published Aug 19, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Orforglipron Topline Results & ADCES 2025 Part 1

0:00 21:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives?

This episode is 21 minutes long.

When was this Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives episode published?

This episode was published on August 19, 2025.

Can I download this Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!